Julia Körholz

Also affiliated with Technische Universität Dresden

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome”.

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

Blood(2022)10.1182/blood.2022018546

N/A

3.2DataRank · unranked

132 citations

Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina +17 more

Interim analysis: Open-label extension study of leniolisib for patients with APDS

Journal of Allergy and Clinical Immunology(2023)10.1016/j.jaci.2023.09.032

N/A

1.2DataRank · unranked

40 citations

Elaine Kulm, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina +15 more

A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysis

Clinical Immunology(2024)10.1016/j.clim.2024.110400

N/A

0.434DataRank · unranked

17 citations

Anna Šedivá, Virgil A. S. H. Dalm, Alessandro Plebani, Catharina Schuetz, Anna Shcherbina +14 more

Clinical manifestations, disease penetrance, and treatment in individuals with SOCS1 insufficiency: a registry-based and population-based study

The Lancet Rheumatology(2025)10.1016/s2665-9913(24)00348-5

N/A

0.416DataRank · unranked

15 citations

Anna Franziska Wolfers, Oleg V. Borisov, Derek Hazard, Timothy Ronan Leahy, Marie Jeanpierre +51 more

IKAROS—how many feathers have you lost: mild and severe phenotypes in IKZF1 deficiency

Frontiers in Pediatrics(2024)10.3389/fped.2024.1345730

N/A

0.269DataRank · unranked

5 citations

Julia Körholz, Hye Sun Kuehn, Agustin A. Gil Silva, Franziska Taube, Karolin Trautmann‐Grill +10 more

Severe Bleeding Diathesis in Siblings with Platelet Dysfunction due to a Novel Nonsense RASGRP2 Mutation

TH Open(2020)10.1055/s-0040-1718910

N/A

0.241DataRank · unranked

4 citations

Nadja Lucas, Franziska Boiti, Karina Althaus, Oliver Tiebel, Mingyan Fang +4 more

Leniolisib treatment for people with activated PI3K delta syndrome (APDS): a plain language summary of the phase 3 study

Future Rare Diseases(2024)10.1080/23995270.2024.2379239

N/A

0DataRank · unranked

0 citations

Sharon Webster, Anna Šedivá, Alessandro Plebani, Catharina Schuetz, Niall Conlon +6 more

Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings

Nature Genetics(2024)10.1038/s41588-024-01836-1

N/A

0DataRank · unranked

49 citations

Magdalena Danyel, Kathrin Grundmann, Theresa Brunet, Hannah Klinkhammer, Tzung‐Chien Hsieh +95 more